openPR Logo
Press release

Clinical Trials Management System Market Key Players Analysis- Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions.

05-26-2025 10:02 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Clinical Trials Management System Market

Clinical Trials Management System Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2034"

The global Clinical Trials Management System market is estimated to reach over 7.3 billion by the year 2034 , exhibiting a CAGR of 13.7% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1684

The growth of the clinical trial management systems (CTMS) market is predominantly driven by the increasing prevalence of chronic and lifestyle-related diseases, coupled with the expanding trend of outsourcing clinical trials to contract research organizations (CROs). As highlighted by the Alzheimer's Association in 2021, Alzheimer's dementia primarily affects individuals aged 65 and above, with prevalence rates of approximately 5.3% among those aged 65 to 74, 13.8% for those aged 75 to 84, and 34.6% for individuals aged 85 and older in the United States. The rising incidence of such chronic conditions is expected to boost demand for targeted clinical trials, thereby accelerating the adoption of CTMS solutions and fostering market expansion.

In addition, substantial investments in research and development (R&D) by pharmaceutical and biopharmaceutical companies are significantly contributing to the CTMS market's growth. According to the 2022 European Federation of Pharmaceutical Industries and Associations (EFPIA) report, pharmaceutical R&D expenditures amounted to EUR 39.7 billion in Europe, USD 72.4 billion in the United States, and CNY 78.5 billion in China in 2020. These considerable R&D investments are instrumental in driving clinical trial activities, subsequently increasing demand for CTMS platforms. Moreover, technological innovations aimed at managing escalating clinical trial costs have further supported market advancement. For example, in September 2021, Total Clinical Trial Management (TCTM) introduced the "TOTAL Diversity" brand, reflecting ongoing industry efforts to enhance clinical trial efficiency and cost-effectiveness.

List of Prominent Players in the Clinical Trials Management System Market:
• IQVIA Inc.;
• Medidata (Dassault Systèmes);
• Oracle;
• DATATRAK International, Inc.;
• Clario
• SimpleTrials;
• Calyx;
• RealTime Software Solutions, LLC;
• Laboratory Corporation of America Holdings;
• Veeva Systems; Wipro Limited;
• PHARMASEAL International Ltd

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

Market Dynamics
Drivers:
The clinical trial management systems (CTMS) market is projected to grow significantly, primarily due to the increasing adoption of decentralized clinical trials (DCTs). These trials, which leverage telemedicine technologies, are also referred to as virtual, digital, mobile, siteless, or remote trials. For example, Labcorp's DCT solution offers an integrated infrastructure, technological tools, and service suite aimed at optimizing the planning and execution of decentralized trials. Furthermore, the growing availability of sophisticated CTMS solutions from leading industry participants is expected to bolster market growth. A notable example is Medidata's Rave CTMS, which provides a robust automation and workflow management platform to enhance trial efficiency and oversight.

Challenges:
Despite a favorable growth trajectory, the CTMS market faces significant challenges concerning data privacy and security. The adoption of cloud-based platforms and big data technologies presents both opportunities and risks. While these tools offer potential cost advantages and operational efficiencies in managing clinical trial processes, they also necessitate stringent data protection measures to ensure compliance and mitigate cybersecurity threats.

Regional Trends:
Within North America, the United States represents the largest market for CTMS, largely attributed to high levels of research and development investment and a growing demand for innovative drug therapies. As reported by ClinicalTrials.gov, as of July 2022, there were 173,066 ongoing clinical trials in North America, with 155,448 of those located in the United States. This substantial volume of clinical activity, combined with increased funding for research initiatives, is anticipated to further stimulate CTMS market growth in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1684

Recent Developments:
• In March 2022, THREAD and Amazon Web Services agreed to work together. AWS will help develop new THREAD platform features by providing scalable automation and integrated AI to enable quicker and more effective trials by enabling higher quality data collecting throughout the clinical study lifecycle.

Segmentation of Clinical Trials Management System Market-
By Solution Type-
• Enterprise
• Site
By Delivery Mode-
• Web & Cloud-based
• On-premise
By Component-
• Software
• Services
By End User-
• Pharmaceutical and Biotechnology Firms
• Medical Device Firms
• CROs & Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/clinical-trials-management-system-market/1684

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trials Management System Market Key Players Analysis- Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions. here

News-ID: 4035473 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Pharmacy Automation Market Exclusive Report with Detailed Study Analysis
Pharmacy Automation Market Exclusive Report with Detailed Study Analysis
"Pharmacy Automation Market" in terms of revenue was estimated to be worth $ 6.7 Bn in 2024 and is poised to reach $ 15.86 Bn by 2034, growing at a CAGR of 9.1% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1483 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Pharmacy Automation market are: • Growing need to minimize medication
PARP Inhibitors Market Exclusive Report on the Latest Revenue and Future Scope
PARP Inhibitors Market Exclusive Report on the Latest Revenue and Future Scope
The global PARP Inhibitors Market Size is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 15.5 Billion by the year 2034 at a 15.2% CAGR during the forecast period for 2025-2034. Request For Free Sample Pages : https://www.insightaceanalytic.com/request-sample/2447 The poly (ADP-ribose) polymerase inhibitors are a collection of 17 enzymes that enzymatically link many units of ADP-ribose into a cohesive chain known as the PAR chain, subsequently transporting them
Nuclear Pharmacy Market Report Latest Trends and Future Opportunities Analysis
Nuclear Pharmacy Market Report Latest Trends and Future Opportunities Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nuclear Pharmacy Market- (By Type (Diagnostic & Therapeutic Nuclear Medicine), By Application (Diagnostic, Therapeutic)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Nuclear Pharmacy Market Size is valued at USD 6.27 Bn in 2024 and is predicted to reach USD 17.96 Bn by the year
Molecular Pharming Market to Market Current Scenario with Future Aspect Analysis
Molecular Pharming Market to Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Molecular Pharming Market Size, Share & Trends Analysis Report By Crop Source (Maize, Barley, Tobacco, Safflower, Rice, Alfalfa), By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations)- Market Outlook

All 5 Releases


More Releases for Trial

Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical